November 28, 2012 — A Pennsylvania start-up is gearing up to launch a molecular saliva test that analyzes biomarkers to detect oral cancer and diabetes. PeriRx is now conducting clinical trials of its diagnostic test, which has attracted the interest of the U.K.’s National Institute for Health Research.

The genesis for the test came from a collaboration between Neil Gottehrer, DDS, a Havertown, PA, dentist who has been practicing for 38 years, and David T.W. Wong, DMD, DMSc, a pioneer in salivary diagnostics who is the associate dean of research and a professor of oral biology at the University of California, Los Angeles (UCLA) School of Dentistry. [Read more…]

In 2008, Pennsylvania doctors, Neil Gottehrer, DDS, and David T.W. Wong, DMD, DMSc, began collaborating on a project to develop a cutting-edge test that would analyze molecular biomarkers in saliva to detect oral cancer. Using Gottehrer’s 38 years of experience as a dentist and Wong’s pioneering research in salivary diagnostics, the two have successfully changed the way doctors, dentists and hygienists screen for oral cancer. [Read more…]